{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:06:39Z","timestamp":1790978799690,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jneuroim.2009.09.010","type":"journal-article","created":{"date-parts":[[2009,10,5]],"date-time":"2009-10-05T09:36:12Z","timestamp":1254735372000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis"],"prefix":"10.1016","volume":"216","author":[{"given":"Zhi-Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Zug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Nuesslein-Hildesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann J.","family":"Schluesener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2009.09.010_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2332\/allergolint.R-07-159","article-title":"Th17 cells and autoimmune encephalomyelitis (EAE\/MS)","volume":"57","author":"Aranami","year":"2008","journal-title":"Allergol. Intern."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.brainresbull.2007.06.023","article-title":"FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis","volume":"74","author":"Balatoni","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib3","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2009.09.010_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2007.04.006","article-title":"Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology","volume":"115","author":"Brinkmann","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/awf133","article-title":"Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis","volume":"125","author":"Brundula","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2009.09.010_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1034\/j.1600-065X.2003.00075.x","article-title":"Lymphoid organ development and cell migration","volume":"195","author":"Cyster","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.immunol.23.021704.115628","article-title":"Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs","volume":"23","author":"Cyster","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nri2295","article-title":"TH17 cells in development: an updated view of their molecular identity and genetic programming","volume":"8","author":"Dong","year":"2008","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1124\/jpet.107.127183","article-title":"Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis","volume":"323","author":"Foster","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1750-3639.2008.00182.x","article-title":"FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood\u2013brain-barrier damage","volume":"19","author":"Foster","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib11","doi-asserted-by":"crossref","first-page":"C253","DOI":"10.1152\/ajpcell.00035.2003","article-title":"A novel method to quantify the turnover and release of monocytes from the bone marrow using the thymidine analog 5\u2032-bromo-2\u2032-deoxyuridine","volume":"285","author":"Goto","year":"2003","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib12","first-page":"61","article-title":"IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice","volume":"119","author":"Haak","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib13","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/brain\/111.5.1039","article-title":"The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations","volume":"111","author":"Hartung","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2009.09.010_bib14","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0024-3205(99)00426-9","article-title":"Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720","volume":"65","author":"Hozumi","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00415-008-3003-z","article-title":"The role of IVIg in autoimmune neuropathies: the latest evidence","volume":"3","author":"Hughes","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/121.3.481","article-title":"Matrix metalloproteinase expression during experimental autoimmune neuritis","volume":"121","author":"Hughes","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2009.09.010_bib17","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.bcp.2007.12.018","article-title":"New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets","volume":"75","author":"Huwiler","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00005344-200003000-00010","article-title":"FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes","volume":"35","author":"Kitabayashi","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/exer.1999.0777","article-title":"Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats","volume":"70","author":"Kurose","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/ndt\/gfm800","article-title":"Th17 cells: a third subset of CD4+ T effector cells involved in organ-specific autoimmunity","volume":"23","author":"Kurts","year":"2008","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/WNL.53.1.62","article-title":"Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy","volume":"53","author":"Leppert","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2009.09.010_bib22","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.4049\/jimmunol.178.9.5425","article-title":"Cutting edge: alternative signaling of Th17 cell development by sphingosine 1-phosphate","volume":"178","author":"Liao","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib23","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/sj.ki.5000360","article-title":"S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure","volume":"69","author":"Lien","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib24","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.175.5.3360","article-title":"Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis","volume":"175","author":"Lubberts","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib25","first-page":"249","article-title":"Diagnosis and treatment in inflammatory neuropathies","volume":"80","author":"Lunn","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2009.09.010_bib26","first-page":"S7","article-title":"Cellular immunity in inflammatory autoimmune neuropathies","volume":"158","author":"Maurer","year":"2002","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib27","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneuro0452","article-title":"From bench to bedside \u2014 experimental rationale for immune-specific therapies in the inflamed peripheral nerve","volume":"3","author":"Meyer zu H\u00f6rste","year":"2007","journal-title":"Nat. Clin. Pract."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib28","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.chembiol.2006.09.017","article-title":"A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model","volume":"13","author":"Pan","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20772","article-title":"Matrix metalloproteinases in neuromuscular disease","volume":"36","author":"Renaud","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2009.09.010_bib31","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1074\/jbc.M311743200","article-title":"Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate","volume":"279","author":"Sanna","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/mp.54.6.381","article-title":"Guillain\u2013Barre syndrome","volume":"54","author":"Winer","year":"2001","journal-title":"J. Clin. Pathol. Mol. Pathol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib33","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1399-0012.2006.00570.x","article-title":"Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants","volume":"20","author":"Yopp","year":"2006","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2174\/138955707781387948","article-title":"FTY720: a most promising immunosuppressant modulating immune cell functions","volume":"7","author":"Zhang","year":"2007","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.expneurol.2007.12.025","article-title":"FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves","volume":"210","author":"Zhang","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1582-4934.2008.00333.x","article-title":"Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline","volume":"13","author":"Zhang","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jneuroim.2009.09.010_bib37","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2990.2009.01016.x","article-title":"FTY720 attenuates lesional interleukin-17 cell accumulation in rat experimental autoimmune neuritis","volume":"35","author":"Zhang","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809003567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809003567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:13:39Z","timestamp":1759047219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572809003567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0165572809003567"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.09.010","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}